Vioxx (Rofecoxib) & Celebrex
What are Vioxx (Rofecoxib) & Celebrex?
Learn about these NSAIDs,
the recall, & the risks.
What is the problem?
associate Vioxx with heart problems, kidney damage,
Who is responsible for Vioxx (Rofecoxib) injuries?
Risks to patients due to lack of warnings.
What is being
done about Rofecoxib?
Class action lawsuit filed against the
maker of Vioxx.
What can you do if Vioxx damaged your kidneys?
You may be entitled to compensation for damages
Heart Attacks and Strokes
Free case inquiry form.
Timeline of what Merck knew about Vioxx, and when
they knew it
Resources on the
Do I have a case?
Vioxx (Rofecoxib) received FDA approval May
Celebrex was approved by the US Food and Drug Administration in December 1998.
Research after the fact exposed some of the potential flaws in the original
studies that were used to gain FDA approval. The FDA was not completely satisfied with
the explanations given by the pharmaceutical companies and, as a result, ordered
changes in the labeling information on both Vioxx (Rofecoxib) and Celebrex
to reflect the most recent and more accurate information.
Apparently the competition for market share between the makers of Vioxx (Rofecoxib)
and the makers of Celebrex may have exacerbated the problems. The manufacturers
of the drugs may have believed that they would be competing with
older NSAIDs like Ibuprofen. However, similarities between Vioxx
and Celebrex forced the pharmaceutical companies to compete with
one another. Both of the medications were heavily promoted. In
the process, some of the facts about these medications were not included in the warnings.
Merck, the company behind Vioxx (Rofecoxib), appeared to be especially aggressive
with its advertising message. In fact, the FDA ordered Merck to tone down
their advertised claims about the benefits of Vioxx (Rofecoxib), saying that
the ads and promotional material for the drug were "false,
lacking in fair balance, or otherwise in violation of the Federal
Food, Drug, and Cosmetic Act and applicable regulations".
It now appears that the health and safety of patients was put
at risk by the lack of warnings supplied by Merck (the makers of Vioxx) and Pharmacia
(the company behind Celebrex). One can only wonder whether the warnings were sufficient, or simply minimal, in order to make profits.
We are not currently accepting new Vioxx cases. You should consult another attorney for an opinion on your case.